Sorafenib-induced eccrine squamous syringometaplasia

Australas J Dermatol. 2022 May;63(2):e189-e190. doi: 10.1111/ajd.13795. Epub 2022 Feb 4.

Authors

Charlotte Velik¹, Nicholas De Rosa¹, Daniel Kearney², Shireen Sidhu¹

Affiliations

¹ Department of Dermatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
² SA Pathology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

PMID: 35119099
DOI: 10.1111/ajd.13795

No abstract available

Keywords: chemotherapy; eccrine glands; metaplasia; sorafenib..

Publication types

Letter

MeSH terms

Carcinoma, Squamous Cell*
Eccrine Glands*
Humans
Metaplasia
Sorafenib / adverse effects

Substances

Sorafenib